Filgrastim is used for the treatment of
**Core Concept**
Filgrastim is a recombinant human granulocyte colony-stimulating factor (G-CSF) analog used to stimulate the production of white blood cells, specifically neutrophils, in the bone marrow. This is particularly useful in patients undergoing chemotherapy, bone marrow transplantation, or suffering from certain infections.
**Why the Correct Answer is Right**
Filgrastim works by binding to the G-CSF receptor on the surface of neutrophil precursors in the bone marrow, triggering a signaling cascade that leads to increased proliferation and differentiation of these cells. This results in an elevated production of mature neutrophils, which are then released into the bloodstream to fight off infections. Filgrastim's mechanism of action is closely related to the G-CSF signaling pathway, which is crucial for the regulation of neutrophil production.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Filgrastim is not typically used to treat anemia, which is a condition characterized by a deficiency of red blood cells or hemoglobin.
**Option B:** This option is incorrect because while Filgrastim can be used to prevent neutropenia (a low count of neutrophils), it is not specifically used to treat neutropenia secondary to HIV infection.
**Option C:** This option is incorrect because Filgrastim is not used to treat chronic myeloid leukemia (CML), a type of cancer that affects the white blood cells.
**Clinical Pearl / High-Yield Fact**
It's essential to remember that Filgrastim can cause splenic enlargement due to the increased production of neutrophils, which can be a side effect of treatment. Additionally, patients on Filgrastim should be monitored for signs of thrombocytopenia (low platelet count) and anemia.
**Correct Answer:** D.